Results 31 to 40 of about 5,659 (182)

Correction: Erythropoietic protoporphyria: case reports for clinical and therapeutic hints [PDF]

open access: yesItalian Journal of Pediatrics
Cristina Tumminelli   +8 more
doaj   +2 more sources

Diagnosis and treatment of icteric hepatitis caused by erythropoietic protoporphyria: A case report

open access: yesLiver Research, 2022
Erythropoietic protoporphyria (EPP) is a rare inherited disease caused by partial deficiency activity of the enzyme ferrochelatase (FECH), resulting in excessive accumulation of protoporphyrin IX in erythrocyte and tissues. Here, we report a patient with
Hanqing Huang   +3 more
doaj   +1 more source

Absorption, metabolism, and excretion of [14C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers

open access: yesPharmacology Research & Perspectives, 2023
Dersimelagon (formerly MT‐7117) is a novel, orally administered nonpeptide small molecule selective agonist for melanocortin 1 receptor currently being investigated for the treatment of erythropoietic protoporphyria, X‐linked protoporphyria, and diffuse ...
Minoru Tsuda   +5 more
doaj   +1 more source

Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria

open access: yes, 2023
Erythropoietic protoporphyria and X-linked protoporphyria are rare genetic photodermatoses. Limited expertise with these disorders among physicians leads to diagnostic delays.
Dickey, Amy   +20 more
core   +2 more sources

Erythropoietic Protoporphyria in a Japanese Population

open access: yesActa Dermato-Venereologica, 2019
Erythropoietic protoporphyria is caused by a partial deficiency of ferrochelatase, which is the last enzyme in the heme biosynthesis pathway. In a typical erythropoietic protoporphyria, photosensitivity initially appears, following the first exposure to ...
Megumi Mizawa   +4 more
doaj   +1 more source

The role of allogeneic stem cell transplantation in severe erythropoietic protoporphyria in adults and young adults: timing and modalities [PDF]

open access: yesHematology, Transfusion and Cell Therapy
Camilla Frieri   +3 more
doaj   +2 more sources

Protection from phototoxic injury during laparoscopic surgery in patients with erythropoietic protoporphyria

open access: yes, 2022
Erythropoietic protoporphyria is a hereditary defect in heme synthesis, causing protoporphyrin deposition and phototoxic reactions after exposure to light, especially at a wavelength of about 400 nm.
Mirosław Kwasny   +7 more
core   +1 more source

Characterization of a novel pathogenic variant in the FECH gene associated with erythropoietic protoporphyria

open access: yesMolecular Genetics and Metabolism Reports, 2019
Erythropoietic protoporphyria (EPP) is an autosomal recessive deficiency in heme biosynthesis due to pathogenic variants in the ferrochelatase gene (FECH). Patients present with lifelong photosensitivity and potential liver disease.
Michele C. Kieke   +9 more
doaj   +1 more source

Erythropoietic protoporphyria in pregnancy

open access: yesJournal of Obstetrics and Gynaecology, 2020
Erythropoietic protoporphyria (EPP) is a rare, genetic condition causing painful, non-blistering photosensitivity, usually without scarring and typically presents in childhood (Ramanujam and Anders...
Elizabeth G, Nevins   +1 more
openaire   +2 more sources

An overview of the cutaneous porphyrias [version 1; referees: 2 approved]

open access: yesF1000Research, 2017
This is an overview of the cutaneous porphyrias. It is a narrative review based on the published literature and my personal experience; it is not based on a formal systematic search of the literature.
Robert Dawe
doaj   +1 more source

Home - About - Disclaimer - Privacy